The Max Foundation (Max) has announced that three patients have started treatment for HER2 negative/HR positive advanced breast cancer (ABC) including CDK4/6 inhibitor therapy in Mozambique through its Max Access Solutions programme.
Trending
- Edo state reaffirms commitment to fight drug abuse
- PAAU student arrested for alleged forced cult initiation
- Africa’s first social justice improv festival opens in Abuja
- Umahi orders temporary halt on Ibadan-Ife-Ilesa road work
- Floods, Windstorm devastate Ebonyi farmlands, shops
- NAF graduates 111 special forces personnel
- Progress on Lagos-Calabar road celebrated
- Lagos residents brave rain for Knorr jollof fest 2026
